Overall Technical outlook

Price Summary

Eris Lifesciences Limited's stock started trading at 1317.9 on 2026-04-30, climbed to 1337.2, fell to 1308.0, and closed 0.38% up at 1322.9, with 120219 shares traded.
The top price for the stock in the last 52 weeks is 1847.7, with the bottom price being 1271.0.
Analysts expect the price of ERIS to vary between 1405.0 and 1940.0, with an average expected price near 1712.6.

Technicals

Support and Resistance: The price sits at 1322.9, supported by 1271.0 and resisted by 1327.6. This indicates a trading range where 1271.0 provides a floor, preventing declines, and 1327.6 acts as a ceiling, limiting further price increases for ERIS.
ERIS supportResistance 74b867
Support/Resistance for ERIS


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
ERIS aroon 74b867
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The BOLL BANDS is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
ERIS bbands 74b867
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR for ERIS continues to indicate a bearish outlook, reinforcing a resistance level that could limit upward potential. This suggests that the market may remain under bearish control, with resistance acting as a barrier to significant upward movement.
ERIS psar 74b867
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: The STOCHASTIC is showing a neutral stance, with no definitive indication of an upward or downward trend for ERIS. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
ERIS stoch 74b867
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
ERIS trippleSMA 74b867
Tripple SMA chart for Eris Lifesciences Limited


To properly assess the technical data of a company, it's important to first look at its fundamentals, such as its earnings, growth potential, and management effectiveness. Equally, understanding the industry trends, competition, and external economic factors that influence the company is vital. This holistic view helps draw meaningful conclusions about the company's technical performance, allowing investors to better gauge its stock price behavior, volatility, and market trends.